Sharon D. Whatley

2.9k total citations
51 papers, 1.8k citations indexed

About

Sharon D. Whatley is a scholar working on Molecular Biology, Rheumatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sharon D. Whatley has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 16 papers in Rheumatology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sharon D. Whatley's work include Porphyrin Metabolism and Disorders (34 papers), Heme Oxygenase-1 and Carbon Monoxide (22 papers) and Folate and B Vitamins Research (16 papers). Sharon D. Whatley is often cited by papers focused on Porphyrin Metabolism and Disorders (34 papers), Heme Oxygenase-1 and Carbon Monoxide (22 papers) and Folate and B Vitamins Research (16 papers). Sharon D. Whatley collaborates with scholars based in United Kingdom, France and Australia. Sharon D. Whatley's co-authors include George H. Elder, Rhian Morgan, Michael N. Badminton, Mark Worwood, Andrew Roberts, Andrew G. Roberts, Hervé Puy, Jean‐Charles Deybach, Jacqueline Woolf and A. Anstey and has published in prestigious journals such as The Lancet, Blood and Hepatology.

In The Last Decade

Sharon D. Whatley

48 papers receiving 1.8k citations

Peers

Sharon D. Whatley
David Kronn United States
Jung Min Ko South Korea
J. E. Wraith United Kingdom
Sharon D. Whatley
Citations per year, relative to Sharon D. Whatley Sharon D. Whatley (= 1×) peers Sarah Dyack

Countries citing papers authored by Sharon D. Whatley

Since Specialization
Citations

This map shows the geographic impact of Sharon D. Whatley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon D. Whatley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon D. Whatley more than expected).

Fields of papers citing papers by Sharon D. Whatley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon D. Whatley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon D. Whatley. The network helps show where Sharon D. Whatley may publish in the future.

Co-authorship network of co-authors of Sharon D. Whatley

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon D. Whatley. A scholar is included among the top collaborators of Sharon D. Whatley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon D. Whatley. Sharon D. Whatley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aarsand, Aasne K., Jordi To‐Figueras, Sharon D. Whatley, Sverre Sandberg, & Caroline Schmitt. (2024). Practical recommendations for biochemical and genetic diagnosis of the porphyrias. Liver International. 45(3). e16012–e16012. 2 indexed citations
2.
Woolf, Jacqueline, Joanne Marsden, Sharon D. Whatley, et al.. (2016). Best practice guidelines on first-line laboratory testing for porphyria. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 54(2). 188–198. 34 indexed citations
3.
Whatley, Sharon D., et al.. (2015). Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales. Atherosclerosis. 240(1). 190–196. 96 indexed citations
4.
Katugampola, Ruwani, Michael N. Badminton, A.Y. Finlay, et al.. (2012). Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases. British Journal of Dermatology. 167(4). 901–913. 47 indexed citations
5.
Anstey, A., A.Y. Finlay, Sharon D. Whatley, et al.. (2012). A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases. British Journal of Dermatology. 167(4). 888–900. 37 indexed citations
6.
Holme, S. Alexander, Sharon D. Whatley, Andrew Roberts, et al.. (2008). Seasonal Palmar Keratoderma in Erythropoietic Protoporphyria Indicates Autosomal Recessive Inheritance. Journal of Investigative Dermatology. 129(3). 599–605. 29 indexed citations
7.
Whatley, Sharon D., Sarah Ducamp, Laurent Gouya, et al.. (2008). C-Terminal Deletions in the ALAS2 Gene Lead to Gain of Function and Cause X-linked Dominant Protoporphyria without Anemia or Iron Overload. The American Journal of Human Genetics. 83(3). 408–414. 200 indexed citations
8.
Whatley, Sharon D., et al.. (2007). Gene Dosage Analysis Identifies Large Deletions of the FECH Gene in 10% of Families with Erythropoietic Protoporphyria. Journal of Investigative Dermatology. 127(12). 2790–2794. 25 indexed citations
9.
Man, Irene, et al.. (2007). Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members. British Journal of Dermatology. 157(5). 1030–1031. 19 indexed citations
10.
Evans, Julie, Hayley Archer, James Colley, et al.. (2005). Early onset seizures and Rett-like features associated with mutations in CDKL5. European Journal of Human Genetics. 13(10). 1113–1120. 135 indexed citations
11.
Charman, Tony, Hayley Archer, Mary Gardiner, et al.. (2005). Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype–phenotype associations in Rett syndrome. European Journal of Human Genetics. 13(10). 1121–1130. 48 indexed citations
12.
Armstrong, D.K.B., P.C. Sharpe, Chelsea Chambers, et al.. (2004). Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern. British Journal of Dermatology. 151(4). 920–923. 13 indexed citations
13.
Evans, Julie, Hayley Archer, Sharon D. Whatley, et al.. (2004). Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls. European Journal of Human Genetics. 13(1). 124–126. 29 indexed citations
14.
Lamoril, J., Hervé Puy, Sharon D. Whatley, et al.. (2001). Characterization of Mutations in the CPO Gene in British Patients Demonstrates Absence of Genotype-Phenotype Correlation and Identifies Relationship between Hereditary Coproporphyria and Harderoporphyria. The American Journal of Human Genetics. 68(5). 1130–1138. 38 indexed citations
15.
Whatley, Sharon D., Andrew Roberts, David H. Llewellyn, et al.. (2000). Non-erythroid form of acute intermittent porphyria caused by promoter and frameshift mutations distant from the coding sequence of exon 1 of the HMBS gene. Human Genetics. 107(3). 243–248. 23 indexed citations
17.
Whatley, Sharon D., Hervé Puy, Rhian Morgan, et al.. (1999). Variegate Porphyria in Western Europe: Identification of PPOX Gene Mutations in 104 Families, Extent of Allelic Heterogeneity, and Absence of Correlation between Phenotype and Type of Mutation. The American Journal of Human Genetics. 65(4). 984–994. 73 indexed citations
18.
Roberts, Andrew, Hervé Puy, Tamara A. Dailey, et al.. (1998). Molecular characterization of homozygous variegate porphyria. Human Molecular Genetics. 7(12). 1921–1925. 44 indexed citations
19.
Roberts, Andrew G., Sharon D. Whatley, Rhian Morgan, Mark Worwood, & George H. Elder. (1997). Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. The Lancet. 349(9048). 321–323. 222 indexed citations
20.
Whatley, Sharon D., Andrew Roberts, & George H. Elder. (1995). De-novo mutation and sporadic presentation of acute intermittent porphyria. The Lancet. 346(8981). 1007–1008. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026